Well-known actress raises rosacea awareness

Actress Cynthia Nixon, best known for her role as Miranda Hobbes in the hit series “Sex and the City,” spoke to dermatologists about her experience with rosacea as part of the Face to Face with Rosacea Symposium at the 2012 Fall Clinical Dermatology Conference on Oct. 4.

Related Videos

Related Content

Latinx, Hispanic Patients with Alopecia Carry Greater Disease Burden Than White Patients

March 22nd 2023

The Cutaneous Connection: Managing Atopic Dermatitis With Emerging Techniques

March 9th 2023

FDA Approves Retifanlimab-Dlwr for the Treatment of Metastatic or Recurrent Locally Advanced MCC

March 22nd 2023

The Cutaneous Connection- Episode 35: QRPs and the Dermatology Practice

December 2nd 2021

New TMB-001 Sub-Analysis Data Published in Clinical and Experimental Dermatology

March 22nd 2023

Roflumilast Safe and Efficient for Patients with Chronic Plaque Psoriasis

March 22nd 2023

Latinx, Hispanic Patients with Alopecia Carry Greater Disease Burden Than White Patients

March 22nd 2023

The Cutaneous Connection: Managing Atopic Dermatitis With Emerging Techniques

March 9th 2023

FDA Approves Retifanlimab-Dlwr for the Treatment of Metastatic or Recurrent Locally Advanced MCC

March 22nd 2023

The Cutaneous Connection- Episode 35: QRPs and the Dermatology Practice

December 2nd 2021

New TMB-001 Sub-Analysis Data Published in Clinical and Experimental Dermatology

March 22nd 2023

Roflumilast Safe and Efficient for Patients with Chronic Plaque Psoriasis

March 22nd 2023

Latinx, Hispanic Patients with Alopecia Carry Greater Disease Burden Than White Patients

March 22nd 2023

The Cutaneous Connection: Managing Atopic Dermatitis With Emerging Techniques

March 9th 2023

FDA Approves Retifanlimab-Dlwr for the Treatment of Metastatic or Recurrent Locally Advanced MCC

March 22nd 2023

The Cutaneous Connection- Episode 35: QRPs and the Dermatology Practice

December 2nd 2021

New TMB-001 Sub-Analysis Data Published in Clinical and Experimental Dermatology

March 22nd 2023

Roflumilast Safe and Efficient for Patients with Chronic Plaque Psoriasis

March 22nd 2023

Related Content

Latinx, Hispanic Patients with Alopecia Carry Greater Disease Burden Than White Patients

Article

The Cutaneous Connection: Managing Atopic Dermatitis With Emerging Techniques

Podcast

FDA Approves Retifanlimab-Dlwr for the Treatment of Metastatic or Recurrent Locally Advanced MCC

Article

The Cutaneous Connection- Episode 35: QRPs and the Dermatology Practice

Podcast

New TMB-001 Sub-Analysis Data Published in Clinical and Experimental Dermatology

Article

Roflumilast Safe and Efficient for Patients with Chronic Plaque Psoriasis

Article